We are live on ! Find out more
BSTC

BioSpecifics Technologies Corp.
BSTC

Delisted

BSTC was delisted on the 1st of December, 2020.

95 hedge funds and large institutions have $177M invested in BioSpecifics Technologies Corp. in 2015 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 37 increasing their positions, 23 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

143% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 7

61% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 23

20% more capital invested

Capital invested by funds: $148M → $177M (+$29M)

10% more funds holding

Funds holding: 8695 (+9)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
95
Holders Change
+9
Holders Change %
+10.47%
% of All Funds
2.49%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
17
Increased
37
Reduced
23
Closed
7
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Creative Planning
101
Creative Planning
Kansas
-$4K -100 Closed
DA
102
Denali Advisors
California
-$1K -27 Closed

BSTC Hedge Fund Activity: Q4 2015 in Review

95 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in BioSpecifics Technologies Corp. (BSTC) for Q4 2015, worth a combined $177M — up 20% from $148M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new BSTC positions and 7 closed out — a net gain of 10 holders — while 37 added to existing stakes and 23 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $3.04M. The largest seller was Bogle Investment Management, exiting entirely with an estimated $2.42M sold.

  • 95 institutional investors held BioSpecifics Technologies Corp. (BSTC) as of Q4 2015, up from 86 in Q3 2015.
  • Funds reported $177M of BioSpecifics Technologies Corp. stock for Q4 2015, up 20% quarter-over-quarter.
  • 17 funds opened new BioSpecifics Technologies Corp. positions in Q4 2015 and 7 closed out, a net change of +10 holders.
  • The largest BioSpecifics Technologies Corp. buyer in Q4 2015 was Renaissance Technologies, an estimated $3.04M added.
  • The largest BioSpecifics Technologies Corp. seller in Q4 2015 was Bogle Investment Management, an estimated $2.42M sold.

Based on aggregated 13F filings for Q4 2015.